Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

China flag China · Delayed Price · Currency is CNY
19.46
+0.23 (1.20%)
At close: Mar 6, 2026
-17.16%
Market Cap 9.04B
Revenue (ttm) 2.57B
Net Income (ttm) 259.43M
Shares Out 464.53M
EPS (ttm) 0.55
PE Ratio 35.60
Forward PE 35.71
Dividend 0.40 (2.06%)
Ex-Dividend Date May 20, 2025
Volume 3,758,687
Average Volume 7,019,748
Open 19.19
Previous Close 19.23
Day's Range 19.16 - 19.48
52-Week Range 19.09 - 26.29
Beta 1.12
RSI 38.60
Earnings Date Apr 23, 2026

About SHE:300482

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious disease, fertility, tumor marker, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rheumatoid arthritis, sex hormone, anemia, gastroenterology, hypertension, thrombus, tumor, inflammation, diabetes, allergy, respiratory infection, kidney... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1992
Employees 3,197
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300482
Full Company Profile

Financial Performance

In 2024, SHE:300482's revenue was 3.06 billion, an increase of 10.85% compared to the previous year's 2.76 billion. Earnings were 561.63 million, an increase of 15.18%.

Financial Statements

News

There is no news available yet.